Table 1.

Inhibition of human pancreatic carcinoma (BXPC-3) cells proliferation in presence of recombinant disintegrins (r-mojastin 1 and r-viridistatin 2).

SAMPLES	BXPC-3‡
r-Mojastin 1	8.7± 0.1 μM
r-Viridistatin 2	10.6 ± 0.5 μM
r-mojastin 1 + r-viridistatin 2	8.0 ± 0.6 μM
Doxorubicin	3.1± 0.2 μM
Paclitaxel	42 ± 2.8 μM
5-Fluorouracil	1114.5 ± 78 μM
Gemtabicine	NA

^‡The results are expressed as CC₅₀.

NA: No activity